Inhalable vaccine of bacterial culture supernatant extract mediates protection against fatal pulmonary anthrax

References

• Kamal SM, Rashid AK, Bakar MA, et al. Anthrax: an update. Asian Pac J Trop Biomed. 2011;1(6):496–501.
   PubMedGoogle Scholar
• Moayeri M, Leppla SH, Vrentas C, et al. Anthrax pathogenesis. Annu Rev Microbiol. 2015;69:185–208.
   PubMed Web of Science ®Google Scholar
• Chambers J, Yarrarapu SNS, Mathai JK. Anthrax Infection. Treasure Island (FL): Statpearls; 2022.
   Google Scholar
• Goel AK. Anthrax: A disease of biowarfare and public health importance. World J Clin Cases. 2015;3(1):20–33.
   PubMed Web of Science ®Google Scholar
• Shlyakhov EN, Rubinstein E. Human live anthrax vaccine in the former USSR. Vaccine. 1994;12(8):727–730.
   PubMed Web of Science ®Google Scholar
• Liu X, Qi X, Zhu L, et al. Genome sequence of Bacillus anthracis attenuated vaccine strain A16R used for human in China. J Biotechnol. 2015;210:15–16.
   PubMed Web of Science ®Google Scholar
• Splino M, Patocka J, Prymula R, et al. Anthrax vaccines. Ann Saudi Med. 2005 Mar-Apr;25(2):143–149.
   PubMed Web of Science ®Google Scholar
• Brey RN. Molecular basis for improved anthrax vaccines. Adv Drug Deliv Rev. 2005;57(9):1266–1292.
   PubMed Web of Science ®Google Scholar
• Collier RJ. Membrane translocation by anthrax toxin. Mol Aspects Med. 2009;30(6):413–422.
   PubMed Web of Science ®Google Scholar
• Klinman DM, Yamamoto M, Tross D, et al. Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine. Expert Opin Biol Ther. 2009;9(12):1477–1486.
   PubMed Web of Science ®Google Scholar
• Song X, Zhang W, Zhai L, et al. Aerosolized intratracheal inoculation of recombinant protective antigen (rPA) vaccine provides protection against inhalational anthrax in(B10):D2), -Hc(0) mice. Front Immunol. 2022;13:819089.
   PubMed Web of Science ®Google Scholar
• Gauthier YP, Tournier JN, Paucod JC, et al. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun. 2009;77(3):1197–1207.
   PubMed Web of Science ®Google Scholar
• Quinn CP, Sabourin CL, Niemuth NA, et al. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques. Clin Vaccine Immunol. 2012;19(11):1730–1745.
   PubMed Web of Science ®Google Scholar
• Shearer JD, Henning L, Sanford DC, et al. Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart. Vaccine. 2021;39(1):1–5.
   PubMed Web of Science ®Google Scholar
• Cohen-Gihon I, Israeli O, Beth-Din A, et al. Whole-genome sequencing of the nonproteolytic Bacillus anthracis V770-NP1-R strain reveals multiple mutations in peptidase loci. Genome Announc. 2014;2(1).
   PubMedGoogle Scholar
• Wang Y, Jiang N, Wang B, et al. Integrated transcriptomic and proteomic analyses reveal the role of NprR in Bacillus anthracis extracellular protease expression regulation and oxidative stress responses. Front Microbiol. 2020;11:590851.
   PubMed Web of Science ®Google Scholar
• Chitlaru T, Gat O, Gozlan Y, et al. Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activities. J Bacteriol. 2006;188(10):3551–3571.
   PubMed Web of Science ®Google Scholar
• Leppla SH. Methods in enzymology. Methods Enzymol. 1988;165:103–116.
   PubMed Web of Science ®Google Scholar
•  Wang Y, Sang S, Zhang X, et al. Efficient genome editing by a miniature CRISPR-AsCas12f1 nuclease in bacillus anthracis. Front Bioeng Biotechnol. 2021;9:825493.
   PubMed Web of Science ®Google Scholar
• Wang YC, Yuan SL, Tao HX, et al. Production and cell surface display of recombinant anthrax protective antigen on the surface layer of attenuated bacillus anthracis. World J Microbiol Biotechnol. 2015;31(2):345–352.
   PubMed Web of Science ®Google Scholar
• Pei H, Xie H, Wang X, et al. Proteomic analysis of differential anther development from sterile/fertile lines in capsicum annuum L. PeerJ. 2022;10:e13168.
   PubMed Web of Science ®Google Scholar
• Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11(12):2301–2319.
   PubMed Web of Science ®Google Scholar
•  Zhang W, Song X, Zhai L, et al. Complete protection against yersinia pestis in BALB/c mouse model elicited by immunization with inhalable formulations of rF1-V10 fusion protein via aerosolized intratracheal inoculation. Front Immunol. 2022;13:793382.
   PubMed Web of Science ®Google Scholar
• Gan C, Luo W, Yu Y, et al. Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin a challenge in mice. NPJ Vaccines. 2021;6(1):87.
   PubMed Web of Science ®Google Scholar
•  Zhang X, Sang S, Guan Q, et al. Oral administration of a shigella 2aT32-based vaccine expressing UreB-HspA fusion antigen with and without parenteral rUreB-HspA boost confers protection against helicobacter pylori in mice model. Front Immunol. 2022;13:894206.
   PubMed Web of Science ®Google Scholar
• Chen P, Liu T, Jiang S, et al. Effects of purified zearalenone on selected immunological and histopathologic measurements of spleen in post-weanling gilts. Anim Nutr. 2017;3(3):212–218.
   PubMedGoogle Scholar
• Labiris NR, Dolovich MB. Pulmonary drug delivery. part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56(6):588–599.
   PubMed Web of Science ®Google Scholar
• Kelly SM, Larsen KR, Darling R, et al. Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against bacillus anthracis. Vaccine. 2021;39(29):3862–3870.
   PubMed Web of Science ®Google Scholar
• Niu M, Ball R. Adverse events after anthrax vaccination reported to the vaccine adverse event reporting system (VAERS), 1990-2007 [vaccine 2009;27:290-297]. Vaccine. 2009 Nov 12;27(48):6654–6655.
   PubMed Web of Science ®Google Scholar
•  Chitlaru T, Israeli M, Bar-Haim E, et al. Next-Generation bacillus anthracis live attenuated spore vaccine based on the htrA(-) (high temperature requirement A) sterne strain. Sci Rep. 2016 Jan 6;6:18908.
   PubMed Web of Science ®Google Scholar
• Zaide G, Elia U, Cohen-Gihon I, et al. Comparative analysis of the global transcriptomic response to oxidative stress of bacillus anthracis htrA-disrupted and parental wild type strains. Microorganisms. 2020;8(12):1896.
   PubMed Web of Science ®Google Scholar
•  Israeli M, Elia U, Rotem S, et al. Distinct contribution of the HtrA protease and PDZ domains to Its function in stress resilience and virulence of bacillus anthracis. Front Microbiol. 2019;10:255.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Somani VK, Gupta S, et al. Development of a novel multiepitope chimeric vaccine against anthrax. Med Microbiol Immunol. 2019;208(2):185–195.
   PubMed Web of Science ®Google Scholar
• Cohen S, Mendelson I, Altboum Z, et al. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun. 2000;68(8):4549–4558.
   PubMed Web of Science ®Google Scholar
• Lv J, Zhang YY, Lu X, et al. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice. Biologicals. 2017;46:130–138.
   PubMed Web of Science ®Google Scholar
• Brossier F, Levy M, Mock M. Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun. 2002;70(2):661–664.
   PubMed Web of Science ®Google Scholar
• Hao XY, Lv Q, Li FD, et al. The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device. Animal Model Exp Med. 2019;2(4):269–281.
   PubMedGoogle Scholar
• Brain JD. Inhalation, deposition, and fate of insulin and other therapeutic proteins. Diabetes Technol Ther. 2007;9(Suppl 1):S-4–S-15.
   Google Scholar
• Sou T, Meeusen EN, de Veer M, et al. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol 2011;29(4):191–198.
   PubMed Web of Science ®Google Scholar
• Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4(6):603–611.
   PubMed Web of Science ®Google Scholar
• Minne A, Louahed J, Mehauden S, et al. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology. 2007;122(3):316–325.
   PubMed Web of Science ®Google Scholar
• Logomasini MA, Stout RR, Marcinkoski R. Jet injection devices for the needle-free administration of compounds, vaccines, and other agents. Int J Pharm Compd. 2013 Jul-Aug;17(4):270–280.
   PubMedGoogle Scholar
• Wu S, Huang J, Zhang Z, et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect Dis. 2021;21(12):1654–1664.
   PubMed Web of Science ®Google Scholar
• Pleasants RA, Hess DR. Aerosol delivery devices for obstructive lung diseases. Respir Care. 2018;63(6):708–733.
   PubMed Web of Science ®Google Scholar
• Wang SH, Kirwan SM, Abraham SN, et al. Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci. 2012;101(1):31–47.
   PubMed Web of Science ®Google Scholar
• Saboo S, Tumban E, Peabody J, et al. Optimized formulation of a thermostable spray-dried virus-like particle vaccine against human papillomavirus. Mol Pharm. 2016;13(5):1646–1655.
   PubMed Web of Science ®Google Scholar